logo

For the Inventor, By the Inventor

Ramat-Hasharon, Israel

Michal Ayalon-Soffer

This inventor holds 17 USPTO granted patents and 6 published patent applications and 2 EPO patents, primarily in G-Protein Coupled Receptors. Top assignee: Compugen Ltd. Corporation. Active years: 2008-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michal Ayalon-Soffer. Retrieved from https://idiyas.com/inventor/michal-ayalon-soffer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 10.9

ph-index = 5

Forward Citations = 211(Granted Patents)


Company Filing History:

goldMedal17 out of 62 
 
Compugen Ltd. Corporation
 patents

Years Active: 2008-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Heparanase
Ischemia-Reperfusion Injury
Peptide Ligands
Polynucleotides
Amino Acid Sequences
Ovarian Cancer
Cardiac Disease
Hepatocyte Growth Factor
MCP-1
Breast Cancer
Prostate Cancer
Brain Natriuretic Peptide
17 patents (USPTO):Explore Patents
1. 9428586 - Heparanase splice variant (2016-08-30),
2. 8828940 - Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands (2014-09-09),
3. 8349801 - Peptide ligands for G-protein coupled receptors (2013-01-08),
4. 7939634 - Polynucleotides encoding polypeptides and methods using same (2011-05-10),
5. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer (2011-03-15),
6. 7884180 - Peptides which bind to G protein-coupled receptors (2011-02-08),
7. 7842459 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis (2010-11-29),
8. 7758862 - Hepatocyte growth factor receptor splice variants and methods of using same (2010-07-20),
9. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease (2010-05-11),
10. 7678769 - Hepatocyte growth factor receptor splice variants and methods of using same (2010-03-16),
11. 7601692 - MCP-1 splice variants and methods of using same (2009-10-13),
12. 7569662 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer (2009-08-04),
13. 7553948 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer (2009-06-30),
14. 7528243 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer (2009-05-05),
15. 7368548 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer (2008-05-06),

Title: Innovator Spotlight: Michal Ayalon-Soffer - Revolutionizing Biomedical Technologies

Introduction:

Meet Michal Ayalon-Soffer, a prolific inventor hailing from Ramat-Hasharon, Israel, who has made significant contributions to the field of biomedical research. With a remarkable portfolio of 17 patents to his name, Michal's innovative work has been pivotal in advancing cutting-edge technologies to address critical medical needs.

Latest Patents:

Among his latest patents is the groundbreaking invention of the Heparanase splice variant. This invention focuses on splice variants of heparanase, diagnostic kits, therapeutic agents, and antibodies, opening new avenues in the treatment of various disorders. Additionally, Michal's method of treating ischemia-reperfusion injury-related disorders by administering GPCR ligands showcases his commitment to developing novel treatment modalities.

Career Highlights:

Michal Ayalon-Soffer is an esteemed member of Compugen Ltd., a leading corporation at the forefront of biomedical innovation. His tenure at Compugen Ltd. has been marked by a steadfast dedication to pushing the boundaries of scientific discovery and translating research into tangible solutions that benefit society.

Collaborations:

In his quest for innovation, Michal has collaborated closely with accomplished colleagues such as Zurit Levine and Dvir Dahary. Together, they have synergized their expertise to drive forward pioneering research initiatives and foster a culture of excellence within the biomedical community.

Conclusion:

In conclusion, Michal Ayalon-Soffer stands as a trailblazing inventor whose inventive spirit and unwavering passion for scientific advancement continue to shape the landscape of biomedical technologies. His contributions resonate across the industry, offering hope and healing through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…